Rajarsi Mandal

University of Pittsburgh, University of Pittsburgh Medical Center, Memorial Sloan Kettering Cancer Center

Papers

Total Citations

283

H-Index

About

Rajarsi Mandal is a leading head and neck surgeon whose research has fundamentally advanced the safety and precision of transoral robotic surgery (TORS) for oropharyngeal cancer. His work centers on two critical challenges: minimizing life-threatening postoperative hemorrhage and optimizing patient quality of life. Mandal’s landmark 2015 study analyzing post-TORS hemorrhage, cited over 100 times, established evidence-based protocols to prevent this rare but serious complication. He further demonstrated that prophylactic transcervical arterial ligation can significantly reduce bleeding severity, a finding with 63 citations that has shaped operative practice. Equally impactful, Mandal showed that TORS alone—without adjuvant radiotherapy—can preserve swallowing function and quality of life in carefully selected patients, challenging the prevailing paradigm of multimodality treatment. His 2016 work on using upfront TORS pathology to tailor adjuvant therapy has helped reduce overtreatment. Through these contributions, Mandal has not only improved surgical outcomes but also championed a more individualized, less toxic approach to oropharyngeal cancer care, making him a pivotal figure in the robotic surgery revolution.